Arrowstreet Capital
MRNA icon

Arrowstreet Capital’s Moderna MRNA Stock Holding History

Arrowstreet Capital’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q2 		– Sell
-5,552
Closed -$956K – 1353
2022
Q1 		$956K Sell
5,552
-493,089
-99% -$83M ﹤0.01% 941
2021
Q4 		$127M Buy
498,641
+84,041
+20% +$24.6M 0.15% 153
2021
Q3 		$160M Buy
+414,600
New +$153M 0.2% 114
2021
Q1 		– Sell
-225,343
Closed -$23.5M – 2420
2020
Q4 		$23.5M Buy
+225,343
New +$22.8M 0.03% 537

Other funds holding MRNA

Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
FP
Flagship Pioneering Cambridge, Massachusetts $1.16B AUM 67.93% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.5B AUM 19.72% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Coatue Management
Coatue Management New York $29.1B AUM 96.54% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Arrowstreet Capital's MRNA Position: Q2 2022 in Review

Arrowstreet Capital sold out of Moderna (MRNA) in Q2 2022, closing a stake of 5,552 shares — an estimated $956K sold.

Arrowstreet Capital first reported a position in MRNA in Q4 2020 and held it in 4 quarters. The position peaked at $160M in Q3 2021. 981 funds tracked by Wall St. Rank hold MRNA as of Q2 2022.

  • Arrowstreet Capital reported no remaining Moderna position as of Q2 2022 after selling out during the quarter.
  • Arrowstreet Capital sold 5,552 Moderna shares in Q2 2022, an estimated $956K.
  • Arrowstreet Capital first reported a position in Moderna in Q4 2020 and held it in 4 quarters.
  • Arrowstreet Capital's Moderna position peaked at $160M in Q3 2021.
  • 981 funds tracked by Wall St. Rank held Moderna as of Q2 2022.

Based on Arrowstreet Capital's 13F filing for Q2 2022, filed 15 Aug 2022.